In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer
Open Access
- 1 December 2022
- journal article
- research article
- Published by Springer Nature in Cell & Bioscience
- Vol. 12 (1) , 1-21
Abstract
Systemic identification of tumor suppressor genes (TSGs) and elucidation of their signaling provide a new angle for understanding of tumorigenesis, which is important for developing successful treatment for lung cancer patients. In our current work, we conducted an in vivo screen for lung cancer TSGs through CRISPR/Cas9 mediated knockout of genes at genome-wide scale. We found that ZNF24 was a potent and clinically relevant TSG of lung cancer. Ectopic expression of ZNF24 arrested lung cancer cells in S phase. Mechanistically, ZNF24 bound to promoter region of P65 to negatively regulate its transcription and thereby the signaling activity of NF-κB pathway. This signaling cascade is clinically relevant. Importantly, we found that combinational inhibition of KRAS, NF-κB, and PD-1 effectively shrank autochthonous KrasG12D/ZNF24−/− lung cancers in transgenic mouse model. Our current work thus revealed an important role played by loss of function of ZNF24 in lung tumorigenesis and shed new light in precision medicine for a portion of lung cancer patients.Keywords
Funding Information
- National Natural Science Foundation of China (81972778, 31800723)
- Basic and Applied Basic Research Foundation of Guangdong Province (2021A1515010461)
- Fundamental Research Funds for Central Universities of the Central South University (21619101)
This publication has 57 references indexed in Scilit:
- Lung tumor NF-κB signaling promotes T cell–mediated immune surveillanceJournal of Clinical Investigation, 2013
- The complexity of NF-κB signaling in inflammation and cancerMolecular Cancer, 2013
- Tumour suppressor genes in chemotherapeutic drug responseBioscience Reports, 2012
- BAY 11-7082 Is a Broad-Spectrum Inhibitor with Anti-Inflammatory Activity against Multiple TargetsMediators of Inflammation, 2012
- NF-kappaB in Lung TumorigenesisCancers, 2011
- Cdh11 Acts as a Tumor Suppressor in a Murine Retinoblastoma Model by Facilitating Tumor Cell DeathPLOS Genetics, 2010
- Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cellsMolecular Cancer, 2009
- A Functional Role for KLF6-SV1 in Lung Adenocarcinoma Prognosis and Chemotherapy ResponseCancer Research, 2008
- Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase DomainPLOS Medicine, 2005
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002